Equifax’s track record of beating consensus estimates, including a 5.6% EPS outperformance in Q2 2026, underpins the 70.5% market-implied probability of another beat when the company reports Q3 results on October 20. Analysts project EPS near $2.22–$2.29 against company guidance of $2.15–$2.25, while revenue is expected to rise about 10% year-over-year to roughly $1.60–$1.70 billion amid double-digit growth in non-mortgage segments. Recent momentum from accelerated lender adoption of VantageScore 4.0 and new offerings such as Mortgage Score Select supports margin expansion and product innovation, though a $100 million settlement tied to legacy data issues and several downward price-target revisions in early October introduce modest caution. Traders view these factors as tilting the odds toward another modest beat while acknowledging housing-market sensitivity and execution risks ahead of the release.